The interplay between the immune response and neoadjuvant therapy in breast cancer
{{output}}
Treatment of early breast cancer is currently experiencing a rapid evolution because of important insight into tumor subtypes and continuous development and improvement of novel therapeutics. Historically considered non-immunogenic, breast cancer has seen a pa... ...
